A new case report details a novel genetic mutation linked to drug resistance in a non-small cell lung cancer patient ...

An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...

In a Phase 1 study, nine people with advanced kidney cancer became cancer free after receiving personalized vaccines.

A new case report was published in Volume 16 of Oncotarget on February 5, 2025, titled “Acquired RUFY1-RET rearrangement as a ...

Can pollution cause it? What about inflammation? And how do tumors spread? Here’s what scientists are learning about this ...

The colon cancer BRAFF mutation study is one of the first to be initiated under the FDA’s Project FrontRunner.

Forkhead box protein L2 (FOXL2) is a protein involved in ovary development and maintenance, among other functions. Mutations in its gene are involved in ovarian failure and granulosa cell tumors, ...

A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, according to new research led by investigators at the Johns Hopkins Kimmel ...

Neoantigen-targeting personalized cancer vaccines (PCVs) are highly immunogenic in high-risk clear cell renal cell carcinoma (RCC) and can target key driver mutations and induce antitumor immunity, ...

Cancer is a leading cause of death worldwide, and its treatment is one of the most complex challenges People with inherited mutations are at a higher risk of developing certain cancers ...